Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Zomedica Files U.S. Provisional Patent Application for Novel Pharmaceutical Formulation

Tuesday, July 12, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

ANN ARBOR (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM), a veterinary pharmaceutical company, today announced that it has filed a provisional application for patent with the United States Patent and Trademark Office (USPTO) for a novel formulation of ZM-006, a pharmaceutical targeting a metabolic disorder in companion animals. This provisional application is based on positive results from both in-vivo and in-vitro studies designed to address the unique formulation requirements of companion animals.

Concurrently, Zomedica opened its second Investigational New Animal Drug (INAD) application with the U.S. Food and Drug Administration Center for Veterinary Medicine for ZM-006.

Read full article here.


Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal